FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer Milrinone Lactate Injection 200 mcg Recall

Milrinone Lactate Injection 200 mcg (0

Pfizer Inc. · New York, NY

Risk level
Class II
Reported by FDA
Jul 24, 2019
Recall ID
D-1487-2019
Check your lot numberHow we source this data

Summary

Pfizer recalled Milrinone Lactate Injection 200 mcg starting Jul 9, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1487-2019 on Jul 24, 2019. Reason: Lack of Assurance of Sterility: Bags have the potential to leak. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Bags have the potential to leak.

Product description

Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection, 20 mg/100 mL, 100 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-23, Barcode (01)00304092776233.

Lot numbers, UPCs & expiration codes

Lot #s: 85-516-KL; 85-517-KL, Exp. 1JAN2020; 86-601-KL; 86-603-KL; 86-618-KL, Exp. 1FEB2020; 87-707-KL, Exp. 1MAR2020; 91-205-KL, Exp. 1JUL2020; 92-306-KL, Exp. 1AUG2020.

Where it was sold

United States, PR, and Guam

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1487-2019
Classification
Class II
Status
Terminated
Recall initiated
Jul 9, 2019
FDA report date
Jul 24, 2019
Quantity
280340 bags
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-1487-2019, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
83267
Address
235 E 42nd St
Code information
Lot #s: 85-516-KL; 85-517-KL, Exp. 1JAN2020; 86-601-KL; 86-603-KL; 86-618-KL, Exp. 1FEB2020; 87-707-KL, Exp. 1MAR2020; 91-205-KL, Exp. 1JUL2020; 92-306-KL, Exp. 1AUG2020.
Postal code
10017-5703
Report date
Jul 24, 2019
Product type
Drugs
Recall number
D-1487-2019
Classification
Class II
Recalling firm
Pfizer Inc.
Product quantity
280340 bags
Termination date
Oct 27, 2021
Reason for recall
Lack of Assurance of Sterility: Bags have the potential to leak.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection, 20 mg/100 mL, 100 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-23, Barcode (01)00304092776233.
Distribution pattern
United States, PR, and Guam
Recall initiation date
Jul 9, 2019
Initial firm notification
Letter
Center classification date
Jul 12, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1487-2019, published Jul 24, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls